Stage iv melanoma
The cost of unresectable stage III or stage IV melanoma in Italy
... unresectable stage III or stage IV ...malignant melanoma (stage III to IV) who presented at the site between 01 July 2005 and 30 June 2006 were entered into a registry where a ...
13
The Expression of p-STAT3 in Stage IV Melanoma: Risk of CNS Metastasis and Survival
... Since the presence of CNS metastasis has been previously demonstrated to be a negative prognostic factor for survival in stage IV melanoma patients, we evaluated this parameter within our dataset and ...
9
BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy
... knowledge this is the first prognostic study in which mutational testing was performed retrospectively within the scope of this analysis and was not built upon already available data acquired from routine testing in ...
7
Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma
... in melanoma cells under certain contexts [34], our data are more consist- ent with a diminished chance of clinical benefit to ipili- mumab in patients with BRAF mutations ...mutant melanoma all had PD as ...
13
High Response Rate to Second Line Combination Antiangiogenic Chemotherapy in Patients with Metastatic Melanoma
... tastatic melanoma, the prognosis remains poor when immune checkpoint inhibition and targeted therapy options are ...in stage IV ...of melanoma and sought to identify prognostic factors ...
12
Clinical significance of plasmacytoid dendritic cells and myeloid derived suppressor cells in melanoma
... in stage IV melanoma ...advanced melanoma have previously been attributed to pDCs rather than mDCs ...in stage IV ...disease stage or other cell ...
9
Update on use of aldesleukin for treatment of high-risk metastatic melanoma
... Early-stage melanoma may often be cured by surgery, although later-stage disease is most often ...unresectable stage III and stage IV melanoma, including three agents ...
11
HLA-B8 association with late-stage melanoma – an immunological lesson?
... the melanoma patient and bone marrow donor groups might still be a ...in stage IV melanoma patients should lead to an increased, rather than a reduced, HLA- B8 frequency when compared to the ...
6
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study
... of melanoma [12-14] many studies have evaluated the combination of chemo- therapy with immunotherapy, particularly regimens con- taining interferon alfa and interleukin-2 (IL-2) ...advanced stage IV ...
9
Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report
... metastatic melanoma managed with a first-line cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) inhibitor (ipilimumab) with maintenance of the graft while on ipili- ...with stage IV ...
5
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma
... with stage IV melanoma with liver and lymph node involvement received Rv for ~ 3 years (and ongoing) and had stable disease with some shrinkage of lymph node lesions and stability of liver ...with ...
8
Original Article Expression of miR-203 is decreased and associated with the prognosis of melanoma patients
... in melanoma is rarely ...of melanoma tissues and adjacent non-cancerous ...in melanoma tissues compared with that in adjacent non-cancerous tissues ...in melanoma This study for the first time ...
6
Original Article KAI1/CD82 and CyclinD1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma
... KAI1/CD82 is a tumor metastasis suppressor and was first found by Dong et al 1995 [4]. The KAI1/CD82 gene encodes 267 amino acids with a molecular weight of 29.6 kDa. The KAI1/ CD82 protein has similar structure to CD82. ...
8
High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry
... cutaneous melanoma (CM) in Europe. Data from the Norwegian Malignant Melanoma Registry (NMMR) enabled us to study patient and tumor characteristics among Norwegian patients, their relations to ...
12
Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma
... Results: Of 436 patients in the intent-to-treat population, 295 were allocated to talimogene laherparepvec and 141 to GM-CSF. Median follow-up in the final OS analysis was 49 months. Median OS was 23.3 months (95% ...
11
Towards Breast Cancer Survivability Prediction Models in Thai Hospital Information Systems
... tree is the stage of breast cancer including Stage I, Stage II, Stage III and Stage IV. The interpretation of the 10-year breast cancer survivability decision tree is presented below. 1[r] ...
219
Shared care in the follow up of early stage melanoma: a qualitative study of Australian melanoma clinicians’ perspectives and models of care
... two melanoma units in NSW, Australia. Melanoma Institute Australia (MIA) is one of the largest melanoma treatment units in the world and hosts the clinics of sur- gical oncologists and ...
9
<p>Irreversible electroporation combined with chemotherapy for unresectable pancreatic carcinoma: a prospective cohort study</p>
... with stage III pancreatic cancer, and can also be used in patients with stage IV pancreatic cancer with limited tumor ...included stage III patients with ...
10
MALIGNANT MELANOMA OF THE HEAD AND NECK
... of melanoma patients presenting with localized disease actually harbor occult nodal ...Adjuvant melanoma therapy imparts a survival benefit in 25% to 50% of ...
12
Relevance of Surgery in Stage IV Gastric Carcinoma
... with Stage IV gastric cancer should or not undergo surgical ...of Stage IV gastric cancer who were treated at Kurume University Hospital from 1995 to ...In Stage IV cases, ...
10